Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Linda M Kalikin"'
Autor:
Lisa A Carmody, Lindsay J Caverly, Bridget K Foster, Mary A M Rogers, Linda M Kalikin, Richard H Simon, Donald R VanDevanter, John J LiPuma
Publikováno v:
PLoS ONE, Vol 13, Iss 3, p e0194060 (2018)
Bacteria that infect the airways of persons with cystic fibrosis (CF) include a group of well-described opportunistic pathogens as well as numerous, mainly obligate or facultative anaerobic species typically not reported by standard sputum culture. W
Externí odkaz:
https://doaj.org/article/589fc9c1ea75408d90f63778a5146b3c
Autor:
Stefanie Widder, Lisa A. Carmody, Kristopher Opron, Linda M. Kalikin, Lindsay J. Caverly, John J. LiPuma
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-13 (2024)
Abstract Polymicrobial infection of the airways is a hallmark of obstructive lung diseases such as cystic fibrosis (CF), non-CF bronchiectasis, and chronic obstructive pulmonary disease. Pulmonary exacerbations (PEx) in these conditions are associate
Externí odkaz:
https://doaj.org/article/cf1a281cf36948d7abd6967ae7644c55
Autor:
Lindsay J Caverly, Lisa A Carmody, Sarah-Jane Haig, Nadine Kotlarz, Linda M Kalikin, Lutgarde Raskin, John J LiPuma
Publikováno v:
PLoS ONE, Vol 11, Iss 4, p e0153876 (2016)
Respiratory tract infections with nontuberculous mycobacteria (NTM) are increasing in prevalence and are a significant cause of lung function decline in individuals with cystic fibrosis (CF). NTM have been detected in culture-independent analyses of
Externí odkaz:
https://doaj.org/article/6fad54f03a0a42e9835b79df6ec76a77
Autor:
Jiangchao Zhao, Lisa A Carmody, Linda M Kalikin, Jun Li, Joseph F Petrosino, Patrick D Schloss, Vincent B Young, John J LiPuma
Publikováno v:
PLoS ONE, Vol 7, Iss 3, p e33127 (2012)
Staphylococcus aureus is a common constituent of the bacterial community inhabiting the airways of persons with cystic fibrosis (CF). Culture-independent studies have shown that this species is often present in relatively high abundance and would the
Externí odkaz:
https://doaj.org/article/3e54746ffefc4702aaac2ffac6383fdf
Autor:
Christina S. Thornton, Amalia S. Magaret, Lisa A. Carmody, Linda M. Kalikin, Richard H. Simon, John J. LiPuma, Lindsay J. Caverly
Publikováno v:
Journal of Cystic Fibrosis.
Autor:
Elizabeth M. Petty, Linda M. Kalikin, Janice L. Loffreda-Wren, Lisa M. Privette, Esther A. Peterson, Maria E. Gonzalez
Supplementary Legends 1-5 from High SEPT9_v1 Expression in Human Breast Cancer Cells Is Associated with Oncogenic Phenotypes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::384a130d98f696986ba3220a9c864044
https://doi.org/10.1158/0008-5472.22371125
https://doi.org/10.1158/0008-5472.22371125
Autor:
Elizabeth M. Petty, Linda M. Kalikin, Janice L. Loffreda-Wren, Lisa M. Privette, Esther A. Peterson, Maria E. Gonzalez
Supplementary Methods from High SEPT9_v1 Expression in Human Breast Cancer Cells Is Associated with Oncogenic Phenotypes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac48e5cff6d119ea00dcbeecdd4c8430
https://doi.org/10.1158/0008-5472.22371122.v1
https://doi.org/10.1158/0008-5472.22371122.v1
Autor:
Elizabeth M. Petty, Linda M. Kalikin, Janice L. Loffreda-Wren, Lisa M. Privette, Esther A. Peterson, Maria E. Gonzalez
Altered expression of the human septin gene, SEPT9, and its murine homologue, Sept9, has been implicated in neoplasia. However, their role(s) in oncogenesis remains poorly understood. We found amplification of SEPT9 in 67% of breast cancer cells (BCC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22d55e5925d12a129de7c1c33366304b
https://doi.org/10.1158/0008-5472.c.6496673
https://doi.org/10.1158/0008-5472.c.6496673
Autor:
Elizabeth M. Petty, Linda M. Kalikin, Janice L. Loffreda-Wren, Lisa M. Privette, Esther A. Peterson, Maria E. Gonzalez
Supplementary Table 1, Figures 1-5 from High SEPT9_v1 Expression in Human Breast Cancer Cells Is Associated with Oncogenic Phenotypes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::036d4fbb0ed56184b6181a0a909e5453
https://doi.org/10.1158/0008-5472.22371119.v1
https://doi.org/10.1158/0008-5472.22371119.v1
Autor:
Lisa A. Carmody, Linda M. Kalikin, Donald R. VanDevanter, Gen Li, Kristopher Opron, Richard H. Simon, Lindsay J. Caverly, John J. LiPuma
Publikováno v:
Journal of Cystic Fibrosis. 21:766-768
Chronic polymicrobial airway infections are a hallmark of cystic fibrosis (CF) lung disease. Antibiotic therapy is a primary treatment of CF pulmonary exacerbations (PEx); however, the impact of episodic antibiotic treatment on airway bacterial commu